Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200914194027.htm
No comments:
Post a Comment